122 related articles for article (PubMed ID: 2047596)
1. Pharmacokinetics of ampicillin and pentobarbital in the course of subclinical fascioliasis in sheep.
Tufenkji AE; Alvinerie M; Larrieu G; Houin G; Galtier P
Res Vet Sci; 1991 Jan; 50(1):75-80. PubMed ID: 2047596
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of sulphobromophthalein, lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep.
Tufenkji AE; Alvinerie M; Houin G; Galtier P
Res Vet Sci; 1987 Nov; 43(3):327-30. PubMed ID: 3444979
[TBL] [Abstract][Full Text] [Related]
3. Comparative incidence of experimental fascioliasis on corticosteroid pharmacokinetics in sheep.
Alvinerie M; Tufenkji AE; Houin G; Toutain PL; Galtier P
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):81-6. PubMed ID: 2576748
[TBL] [Abstract][Full Text] [Related]
4. Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep.
Galtier P; Coulet M; Sutra JF; Biro-Sauveur B; Alvinerie M
Exp Parasitol; 1994 Sep; 79(2):166-76. PubMed ID: 7914496
[TBL] [Abstract][Full Text] [Related]
5. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
[TBL] [Abstract][Full Text] [Related]
6. Antipyrine, erythromycin and oxytetracycline disposition in experimental fasciolosis.
Burrows GE; Tasler J; Boray JC; Egerton J
Res Vet Sci; 1992 Sep; 53(2):191-7. PubMed ID: 1439209
[TBL] [Abstract][Full Text] [Related]
7. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
8. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
[TBL] [Abstract][Full Text] [Related]
9. Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.
Benchaoui HA; McKellar QA
Xenobiotica; 1993 Apr; 23(4):439-48. PubMed ID: 8101676
[TBL] [Abstract][Full Text] [Related]
10. Compared N-demethylation of veterinary drugs by microsomes from normal and fluke-infected sheep livers.
Galtier P; Kaddouri M; Eeckhoutte C
J Vet Pharmacol Ther; 1993 Mar; 16(1):106-9. PubMed ID: 8478993
[No Abstract] [Full Text] [Related]
11. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
[TBL] [Abstract][Full Text] [Related]
12. Chronic subclinical fascioliasis in sheep: effects on food intake, food utilisation and blood constituents.
Sykes AR; Coop RL; Rushton B
Res Vet Sci; 1980 Jan; 28(1):63-70. PubMed ID: 7375735
[No Abstract] [Full Text] [Related]
13. Aberrant energy-linked reactions in mitochondria isolated from the livers of sheep infected with the liver fluke Fasciola hepatica.
Rule CJ; Hanisch MJ; Behm CA; Bygrave FL
Int J Parasitol; 1991 Jun; 21(3):353-55. PubMed ID: 1894433
[TBL] [Abstract][Full Text] [Related]
14. The effect of route of infection on acquired resistance to Fasciola hepatica in the rat and sheep.
Kelly JD; Campbell NJ
Res Vet Sci; 1979 Sep; 27(2):205-9. PubMed ID: 523806
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica infection in sheep: changes in liver metabolism.
Lenton LM; Bygrave FL; Behm CA; Boray JC
Res Vet Sci; 1996 Sep; 61(2):152-6. PubMed ID: 8880986
[TBL] [Abstract][Full Text] [Related]
16. Decrease in albendazole sulphonation during experimental fascioliasis in sheep.
Galtier P; Alvinerie M; Plusquellec Y; Tufenkji AE; Houin G
Xenobiotica; 1991 Jul; 21(7):917-24. PubMed ID: 1776267
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica.
Calléja C; Bigot K; Eeckhoutte C; Sibille P; Boulard C; Galtier P
Int J Parasitol; 2000 Jul; 30(8):953-8. PubMed ID: 10927086
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological basis for hepatic drug metabolism in sheep.
Galtier P; Alvinerie M
Vet Res; 1996; 27(4-5):363-72. PubMed ID: 8822607
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and pharmacokinetics of OZ78 and MT04 against a natural infection with Fasciola hepatica in sheep.
Meister I; Duthaler U; Huwyler J; Rinaldi L; Bosco A; Cringoli G; Keiser J
Vet Parasitol; 2013 Nov; 198(1-2):102-10. PubMed ID: 24011678
[TBL] [Abstract][Full Text] [Related]
20. The ability of diamphenethide to control immature Fasciola hepatica in sheep at a lower than standard dose level.
Rowlands DT; Clampitt RB; Macpherson IS
Vet Rec; 1985 Feb; 116(7):182-4. PubMed ID: 2859685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
